Developing new active ingredients requires specialized knowledge and experts. Even converting recipes for mass production requires specialist expertise. Many active ingredients for treating tumors are highly toxic and thus have special handling requirements, requiring high-containment facilities. Therefore a significant investment in both time and money has been expended.
Heraeus supports its customers in the exclusive synthesis of cytotoxic compounds from the research stage to registration to market launch. With these comprehensive services, customers are free to focus on their core business and transform their innovative ideas into commercial products.
More than 40 years of experience in the field of cytotoxic APIs is the foundation of our exclusive contract manufacturing services:
- Heraeus' high-containment systems ensure the highest technological standard.
- Scientists and experts contribute extensive knowledge and experience to each project.
- Contract manufacturing includes batches from gram to fully commercial scale.
- With comprehensive GMP documentation and outstanding global regulatory support we offer the full-service package.
- Heraeus strictly protects customers’ IP.
Save time and money with Heraeus as a qualified partner. We are able to provide consultation and find the right solutions for any challenges you may face.